ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
7
views
0
references
Top references
cited by
5
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,111
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT.
Author(s):
S. Sharma
,
K D Bagshawe
Publication date:
1996-11-30
Journal:
Transplantation Proceedings
Keywords:
Adenocarcinoma
,
immunology
,
therapy
,
Adult
,
Aged
,
Antibodies, Monoclonal
,
therapeutic use
,
Antibody Formation
,
drug effects
,
Colonic Neoplasms
,
Colorectal Neoplasms
,
Cyclosporine
,
adverse effects
,
Humans
,
Immunoglobulin G
,
biosynthesis
,
blood
,
Immunoglobulin M
,
Immunosuppressive Agents
,
Immunotherapy
,
Middle Aged
,
Pilot Projects
,
Prodrugs
,
metabolism
,
Rectal Neoplasms
,
gamma-Glutamyl Hydrolase
,
administration & dosage
Read this article at
ScienceOpen
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Drug_transporters
Author and article information
Journal
PubMed ID::
8962223
ScienceOpen disciplines:
Chemistry
Keywords:
Adenocarcinoma
,
immunology
,
therapy
,
Adult
,
Aged
,
Antibodies, Monoclonal
,
therapeutic use
,
Antibody Formation
,
drug effects
,
Colonic Neoplasms
,
Colorectal Neoplasms
,
Cyclosporine
,
adverse effects
,
Humans
,
Immunoglobulin G
,
biosynthesis
,
blood
,
Immunoglobulin M
,
Immunosuppressive Agents
,
Immunotherapy
,
Middle Aged
,
Pilot Projects
,
Prodrugs
,
metabolism
,
Rectal Neoplasms
,
gamma-Glutamyl Hydrolase
,
administration & dosage
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adenocarcinoma
,
immunology
,
therapy
,
Adult
,
Aged
,
Antibodies, Monoclonal
,
therapeutic use
,
Antibody Formation
,
drug effects
,
Colonic Neoplasms
,
Colorectal Neoplasms
,
Cyclosporine
,
adverse effects
,
Humans
,
Immunoglobulin G
,
biosynthesis
,
blood
,
Immunoglobulin M
,
Immunosuppressive Agents
,
Immunotherapy
,
Middle Aged
,
Pilot Projects
,
Prodrugs
,
metabolism
,
Rectal Neoplasms
,
gamma-Glutamyl Hydrolase
,
administration & dosage
Comments
Comment on this article
Sign in to comment
Similar content
2,111
Effect of cyclosporine on immunogenicity of a bacterial enzyme carboxypeptidase G2 in ADEPT
Authors:
SK Sharma
,
KD Bagshawe
,
RG Melton
…
Preparation of the Key Intermediate in a Novel Synthesis of ZD9063P: The Chemical Component of ADEPT, a Targeted Cytotoxic Therapy
Authors:
David M. G. Martin
,
Pawel Siedlecki
Advancement of educational performance through teacher support (ADEPTS): an MHRD-UNICEF initiative
Authors:
See all similar
Cited by
5
Antibody Directed Enzyme Prodrug Therapy (ADEPT): Trials and tribulations
Authors:
Surinder K. Sharma
,
Kenneth D. Bagshawe
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours
Authors:
R Francis
,
Reuben Sharma
,
C Springer
…
The past, present, and future of enzyme-based therapies
Authors:
Jennifer N. Hennigan
,
Michael D. Lynch
See all cited by